|
|
||||||||
1 The Diabetes Research Laboratory, Winthrop University Hospital, Mineola 11501; 3 School of Medicine, State University of New York, Stony Brook, New York 11794; and 2 First Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507, Japan
Our laboratory has recently demonstrated that insulin induces relaxation of vascular smooth muscle cells (VSMCs) by activating myosin-bound phosphatase (MBP) and by inhibiting Rho kinase (Begum N, Duddy N, Sandu OA, Reinzie J, and Ragolia L. Mol Endocrinol 14: 1365-1376, 2000). In this study, we tested the hypothesis that insulin via the nitric oxide (NO)/cGMP pathway may inactivate Rho, resulting in a decrease in phosphorylation of the myosin-bound subunit (MBSThr695) of MBP and in its activation. Treatment of confluent serum-starved VSMCs with insulin prevented thrombin-induced increases in membrane-associated RhoA, Rho kinase activation, and site-specific phosphorylation of MBSThr695 of MBP and caused MBP activation. Preexposure to NG-monomethyl-L-arginine, a NO synthase inhibitor, and R-p-8-(4-chlorophenylthio)cGMP, a cGMP antagonist, attenuated insulin's inhibitory effect on Rho translocation and restored thrombin-mediated Rho kinase activation and site-specific MBSThr695 phosphorylation, resulting in MBP inactivation. In contrast, 8-bromo-cGMP, a cGMP agonist, mimicked insulin's inhibitory effects by abolishing thrombin-mediated Rho signaling and promoted dephosphorylation of MBSThr695. Furthermore, expression of a dominant-negative RhoA decreased basal as well as thrombin-induced MBSThr695 phosphorylation and caused insulin activation of MBP. Collectively, these results indicate that insulin inhibits Rho signaling by decreasing RhoA translocation via the NO/cGMP signaling pathway to cause MBP activation via site-specific dephosphorylation of its regulatory subunit MBS.
myosin-bound phosphatase site-specific phosphorylation; myosin-bound phosphatase activation; vasodilation; Rho kinase; hypertension
This article has been cited by other articles:
![]() |
D. W. Nuno, J. S. Harrod, and K. G. Lamping Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1469 - H1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, T. Palaia, and L. Ragolia Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation Am J Physiol Cell Physiol, February 1, 2009; 296(2): C327 - C338. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats Cardiovasc Res, July 15, 2008; 79(2): 322 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Zuckerbraun, D. A. Stoyanovsky, R. Sengupta, R. A. Shapiro, B. A. Ozanich, J. Rao, J. E. Barbato, and E. Tzeng Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA Am J Physiol Cell Physiol, February 1, 2007; 292(2): C824 - C831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee and L. Ragolia AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1355 - C1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Teixeira, Z. Ying, and R. C. Webb Proerectile Effects of the Rho-Kinase Inhibitor (S)-(+)-2-Methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the Rat Penis J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Erdos, J. A. Snipes, B. Kis, A. W. Miller, and D. W. Busija Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1456 - R1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagaoka, Y. Morio, N. Casanova, N. Bauer, S. Gebb, I. McMurtry, and M. Oka Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L665 - L672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1597 - H1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, Y. Yang, S. Zhang, and A. M. Kahn Insulin-Stimulated Hydrogen Peroxide Increases Guanylate Cyclase Activity in Vascular Smooth Muscle Hypertension, October 1, 2003; 42(4): 569 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, Y. Yang, B. C. Kone, J. C. Allen, and A. M. Kahn Insulin-Stimulated Cyclic Guanosine Monophosphate Inhibits Vascular Smooth Muscle Cell Migration by Inhibiting Ca/Calmodulin-Dependent Protein Kinase II Circulation, March 25, 2003; 107(11): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sauzeau, M. Rolli-Derkinderen, C. Marionneau, G. Loirand, and P. Pacaud RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation J. Biol. Chem., March 7, 2003; 278(11): 9472 - 9480. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kitazawa, M. Eto, T. P Woodsome, and M. Khalequzzaman Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle J. Physiol., February 1, 2003; 546(3): 879 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yan, D. Kim, T. Aizawa, and B. C. Berk Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 26 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gudi, J. C. Chen, D. E. Casteel, T. M. Seasholtz, G. R. Boss, and R. B. Pilz cGMP-dependent Protein Kinase Inhibits Serum-response Element-dependent Transcription by Inhibiting Rho Activation and Functions J. Biol. Chem., September 27, 2002; 277(40): 37382 - 37393. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Begum, O. A. Sandu, M. Ito, S. M. Lohmann, and A. Smolenski Active Rho Kinase (ROK-alpha ) Associates with Insulin Receptor Substrate-1 and Inhibits Insulin Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., February 15, 2002; 277(8): 6214 - 6222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |